REGENESIS · MSCEXOS

The New Human Is Already Here.

"The question is whether your protocols are ready."

THE STANDARD

"In a market flooded with unverifiable
products from opaque sources,
regulatory clarity is not a differentiator.
It is the only thing that matters."

Most biologics distributed in the Americas today cannot answer a simple question: where, exactly, did they come from — and under what standard were they manufactured? MSCExos was built to answer that question with absolute certainty — for every product, every order, every patient.

Human hand — warm natural light
REGENERATIVE MEDICINE INFRASTRUCTURE

The Clinical Infrastructure Partner for the World's Most Demanding Practices.

MSCExos connects ATMP-certified European biologics and US FDA-compliant products to the clinics leading this transformation. We are not a catalog. We are not a vendor. We are the operating system on which great regenerative medicine practices run their most differentiated programs.

0% Exosome purity
0B Particles per vial
0+ Therapeutic peptides
OUR MANUFACTURING PARTNERS

Two Hemispheres.
One Standard.

MSCExos is the only distributor in the Americas with certified access to both a European ATMP-authorized laboratory and a US-based FDA-accredited cord blood institution — giving partner clinics the right standard for every market they serve.

Hand holding a glass vial toward light — ATMP-certified precision
EUROPE

ATMP-Certified
European Laboratory

Our European manufacturing partner operates under EMA oversight with Hospital Exemption authorization as an ATMP-certified Advanced Therapy Medicinal Products laboratory — the same regulatory standard applied to the most advanced cell therapies in the world. This certification cannot be replicated by a compounding pharmacy or any gray-market source.

  • EMA-overseen production
  • Hospital Exemption authorization
  • ATMP classification — European Union
  • cGMP-certified facility
  • Wharton's Jelly MSC source
  • MUSE-enriched exosomes, 99% purity
Cryogenic storage tanks — cord blood preservation
UNITED STATES

BioXGel —
Cord for Life® Source

Our US domestic biologic line, BioXGel, is sourced from Cord for Life® — an FDA-accredited cord blood and cord tissue bank operating since 1995, with over 2,200 successful stem cell transplant cases on record. Their proprietary PREMIERMAX® processing method maximizes stem cell recovery and transplant safety. US peptide therapeutics sourced from compliant domestic manufacturers.

  • FDA-accredited in-house facility
  • Operating since 1995
  • 2,200+ transplant cases on record
  • PREMIERMAX® processing method
  • Cord blood and cord tissue sourced
  • US-compliant peptide therapeutics

Whether your clinic is in Miami, Mexico City, São Paulo, Bogotá, or Madrid — MSCExos delivers compliance-grade biologics appropriate to your regulatory environment.

THE PORTFOLIO

Not a Catalog.
A Curated Platform.

Three product families. Each selected because it meets a standard most of the market cannot match.

Luminous translucent sphere — MUSE-enriched exosome
01

MUSE-Enriched Exosomes

European ATMP-Certified

Derived from Wharton's Jelly MSC, enriched with MUSE cells — a rare pluripotent subpopulation with up to 10x the potency of conventional MSCs. 99% purity. 100 billion particles per vial. Lyophilized for stable cold-chain transport and reconstitution at the point of care.

99% purity 100B particles/vial MUSE-enriched Lyophilized
Backlit leaf vascular network — living systems, cellular pathways
02

MUSE Cells & MSC Therapy

Advanced Cellular Protocols

Living mesenchymal stem cells with 88.6% post-thaw viability, processed fresh — never pre-frozen. MUSE cells offer true pluripotency and long-term engraftment for severe tissue damage requiring cellular replacement. 100 million cells per vial. CD73: 100%, CD90: 99.6%, CD105: 99.3%.

88.6% viability 100M cells/vial Fresh processed Pluripotent
Therapeutic Peptides — molecular chemistry
03

Therapeutic Peptides

US-Sourced, Clinically Curated

70+ specialized bioactive peptides across five therapeutic categories: immune modulation, tissue regeneration, mitochondrial function, hormonal balance, and performance optimization. US-sourced from compliant domestic manufacturers. Complete clinical protocols included with every order.

70+ compounds US-sourced 5 therapeutic categories Protocols included
THE DIFFERENTIATOR

The Infrastructure
No One Can Buy.

Compliance, education, scientific provenance, and curatorship of the new. These are not features. They are the foundation of every partnership MSCExos builds.

01 —

Compliance as the Luxury

European ATMP certification and US FDA-accredited sourcing create a legal and quality barrier that compounding pharmacies and gray-market distributors cannot cross. This is not a feature. It is the foundation.

02 —

Not a Vendor. An Operating System.

Partner clinics receive clinical education libraries, peer-reviewed protocol documentation, co-marketing assets, and access to the Regenesis thought leadership platform. We build the practice around the product — not the other way around.

03 —

Peer-Reviewed. Clinically Associated.

Our European laboratory partner includes a credentialed Qualified Person at a GMP ATMP-certified facility. Published clinical protocols — including novel ASD treatment data and neurological protocols — position partner clinics with evidence-first authority in front of their patients.

04 —

We Lead. We Don't Follow.

MSCExos identifies what the next five years of regenerative medicine will look like and gives partner clinics access today. Through Regenesis magazine, we are the editorial authority on what is next — not a catalog of what already exists.

FOR CLINICAL PARTNERS

Built for Clinics That
Compete on Excellence.

Luxury clinic consultation — precision medicine

MSCExos does not supply clinics. It transforms them.

Partner clinics gain access to products manufactured under European ATMP certification with full Hospital Exemption authorization — and US FDA-accredited domestic biologics for practices serving the North American market.

White-label clinical education materials for your own medical staff. Published peer-reviewed protocol documentation presented to your patients as part of an evidence-first care philosophy.

A distribution relationship structured for long-term alignment and regional exclusivity. Not transactional volume. Not a catalog. A partnership.

PARTNERSHIP TERMS
Minimum Order No minimum — first order
Cold Chain 72-hour validated transport
Clinical Support Dedicated onboarding + protocols
Co-Marketing REGENESIS + MSCExos Academy
Exclusivity Regional terms available
Order Platform formulary.mscexos.com
Onboarding onboarding.mscexos.com
Begin the Conversation
CLINICAL SEGMENTS

Three Markets.
One Infrastructure.

01

Longevity & Precision Medicine

Protocol-driven practices focused on biological age reversal, healthspan optimization, and cellular regeneration. MSCExos provides the exosome and MUSE cell portfolio with the clinical evidence framework to match.

02

Integrative & Functional Medicine

Clinics treating chronic inflammatory conditions, neurological disorders, autoimmune dysfunction, and post-surgical recovery. Our product suite and peer-reviewed protocols support evidence-based cellular therapy programs.

03

Aesthetics & Regenerative MedSpa

Results-first practices offering skin rejuvenation, hair restoration, and post-procedure recovery. Exosomes deliver 100x more growth factors than PRP — with zero blood draw and a defensible quality story that elevates the clinic brand.

REGENESIS

The clinics that will define
the next decade of medicine
are already choosing their
infrastructure partners.

"The question is which side of that line you are on."

Begin the Conversation

clinics@mscexos.com · +1 463.465.2224